Should You Buy Envista Holdings Corporation Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Envista Holdings Corporation (NVST) is rated as a strong fundamental performer with a QOC score of 8.3/10. Trading at $24.73, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.
The short answer: 5 of 10 CirclFi valuation models project upside for Envista Holdings Corporation (NVST) at $24.73 — the models are evenly split, with a Quality Score of 8.3/10 and Value-Trap risk of 12/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Envista Holdings Corporation (NVST) in 2026?
What Is the Bull Case vs the Bear Case for Envista Holdings Corporation (NVST)?
| Bull case — $45.42 target (+83.7%) | Bear case — $4.04 target (-83.7%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Envista Holdings Corporation's score of 8.3/10 reflects durable competitive advantages that should sustain earnings power through market cycles. | According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $4.04 (-83.7%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $45.42 (+83.7%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +167.3% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
How Does NVST Compare to Its Medical Instruments & Supplies Peers?
Valuation data pages: BDX · PDEX · ALGN · UTMD · NEPH · RGEN · NXGL · XRAY · TUTH · ISRG · RMD
Which Other Stocks Score Like NVST on Quality?
Closest companies to NVST’s Quality of Company score of 8.3/10, across all industries.
- HON — Honeywell International Inc. (QOC 8.3) · analysis
- MKTX — MarketAxess Holdings Inc. (QOC 8.3) · analysis
- IIIN — Insteel Industries Inc. (QOC 8.3) · analysis
- PNTG — The Pennant Group, Inc. (QOC 8.3) · analysis
- JLL — Jones Lang LaSalle Incorporated (QOC 8.3) · analysis
- TSSI — TSS, Inc. (QOC 8.3) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Instruments & Supplies Screens Does NVST Appear In?
So Is Envista Holdings Corporation (NVST) Worth Buying in 2026?
Our models don't have a clear verdict on Envista Holdings Corporation. At $24.73 vs. $24.12 median fair value, the median upside of -2.5% masks significant model disagreement (+167.3% spread). With quality at 8.3/10, this is a stock where the margin of error is wide and additional fundamental research is strongly recommended.
These are quantitative model outputs, not investment recommendations. Envista Holdings Corporation's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About NVST Stock?
Should I buy NVST stock right now?
Based on CirclFi's multi-model analysis, 5 of 10 models see upside for NVST at $24.73. The models are divided, which means the investment case depends heavily on your assumptions about Envista Holdings Corporation's future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Envista Holdings Corporation?
Key risks include: wide model disagreement (1023% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.
How does NVST compare to its competitors?
Among Medical Instruments & Supplies peers, NVST holds a Quality Score of 8.3/10. Comparable companies include BDX (QOC 8.3), PDEX (QOC 8.2), ALGN (QOC 8.4). The relative ranking helps investors identify whether NVST offers better fundamental quality than alternatives in the same sector.
Is NVST a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. NVST's Quality Score of 8.3/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy NVST at?
CirclFi does not provide target buy prices or price alerts. However, our 10 active models produce fair value estimates ranging from $4.04 to $45.42. At $24.73, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for NVST.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad